Kāriki Pharma is on track to be the first company to enter the New Zealand medicinal cannabis market and export products developed in New Zealand. The company is the only licensed company to have direct experience distributing medicinal cannabis products internationally.
Through the company's distribution partner Altum, import orders are in place to ensure that there will be partner-supplied product available for customers as soon as regulations take effect. Letters of Intent for off-take arrangements are in place with cannabis cultivation facilities to provide Kāriki Pharma with sufficient starting material before developing its own growing capabilities. After entering the local market, Kāriki Pharma aims to expand its manufacturing capability to meet the large international demand for New Zealand-produced medicinal cannabis products.